These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 25085312

  • 1. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
    Battisti S, Guida FM, Pagliara E, Tonini G, Zobel BB, Santini D.
    Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
    [No Abstract] [Full Text] [Related]

  • 2. Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?
    Nordlinger B, Poston GJ, Goldberg RM.
    J Clin Oncol; 2015 Jan 20; 33(3):241-3. PubMed ID: 25403221
    [No Abstract] [Full Text] [Related]

  • 3. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
    Garant A, Des Groseilliers S, Martin L, Ferland É, Vuong T.
    Clin Oncol (R Coll Radiol); 2011 Sep 20; 23(7):497-8. PubMed ID: 21576010
    [No Abstract] [Full Text] [Related]

  • 4. Metastatic colorectal cancer: is surgery necessary?
    Schmidt C.
    J Natl Cancer Inst; 2009 Aug 19; 101(16):1113-5. PubMed ID: 19671774
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review.
    Walter H, Thomas AL.
    Br J Cancer; 2013 Jun 25; 108(12):2417-8. PubMed ID: 23801031
    [No Abstract] [Full Text] [Related]

  • 8. Bevacizumab in the treatment of colorectal cancer.
    Marshall JL.
    Clin Adv Hematol Oncol; 2007 Jan 25; 5(1 Suppl 1):8-9. PubMed ID: 17491585
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
    Guo X, Liu TS, Yu YY, Zhou YH, Chen Y, Zhuang RY, Cui YH.
    Zhonghua Zhong Liu Za Zhi; 2013 Aug 25; 35(8):604-7. PubMed ID: 24314219
    [Abstract] [Full Text] [Related]

  • 13. Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens.
    Krstovski N, Dokmanovic L, Lazic J, Rodic P, Paripovic L, Janic D.
    Pediatr Hematol Oncol; 2012 Sep 25; 29(6):549-50. PubMed ID: 22839297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.